Your browser doesn't support javascript.
loading
Breast cancer and cervical cancer: a comparison of the period before and during the COVID-19 pandemic.
Stevanato, Kely Paviani; Santos, Lander Dos; Pelloso, Fernando Castilho; Borghesan, Deise Helena Pelloso; Consolaro, Marcia Edilaine Lopes; de Almeida, Rosane; Huber, Isabela Morais Tavares; Egger, Paulo; Alarcão, Ana Carolina Jacinto; de Souza, Rebeca Rosa; Ribeiro, Helena Fiats; Camparoto, Camila Wohlenberg; Bitencourt, Mariá Romanio; Borba, Pedro Beraldo; Silva, Lincoln Luis; de Barros Carvalho, Maria Dalva; Pelloso, Sandra Marisa.
Afiliação
  • Stevanato KP; Health Sciences Center, State University of Maringá-UEM, Colombo Avenue, 5790, Maringá, Paraná, 87020-900, Brazil. kelystevanato@gmail.com.
  • Santos LD; Health Sciences Center, State University of Maringá-UEM, Colombo Avenue, 5790, Maringá, Paraná, 87020-900, Brazil.
  • Pelloso FC; Secretary Health Curitiba, Curitiba, 80060-240, Brazil.
  • Borghesan DHP; Catholic College of Mato Grosso, Várzea Grande, 78070-200, Brazil.
  • Consolaro MEL; Department of Biomedicine, State University of Maringá-UEM, Maringá, 87020-900, Brazil.
  • de Almeida R; Regional University Hospital of Maringá, Maringá, 87020-900, Brazil.
  • Huber IMT; University Center UNINGÁ, Maringá, 87035-510, Brazil.
  • Egger P; Health Sciences Center, State University of Maringá-UEM, Colombo Avenue, 5790, Maringá, Paraná, 87020-900, Brazil.
  • Alarcão ACJ; Health Sciences Center, State University of Maringá-UEM, Colombo Avenue, 5790, Maringá, Paraná, 87020-900, Brazil.
  • de Souza RR; Nursing Center, State University of Paraná-UNESPAR, Paranavaí, Paraná, 87701-000, Brazil.
  • Ribeiro HF; Health Sciences Center, State University of Maringá-UEM, Colombo Avenue, 5790, Maringá, Paraná, 87020-900, Brazil.
  • Camparoto CW; Health Sciences Center, State University of Maringá-UEM, Colombo Avenue, 5790, Maringá, Paraná, 87020-900, Brazil.
  • Bitencourt MR; Health Sciences Center, State University of Maringá-UEM, Colombo Avenue, 5790, Maringá, Paraná, 87020-900, Brazil.
  • Borba PB; Unimar, Marilia, São Paulo, 17525-902, Brazil.
  • Silva LL; Health Sciences Center, State University of Maringá-UEM, Colombo Avenue, 5790, Maringá, Paraná, 87020-900, Brazil.
  • de Barros Carvalho MD; Health Sciences Center, State University of Maringá-UEM, Colombo Avenue, 5790, Maringá, Paraná, 87020-900, Brazil.
  • Pelloso SM; Health Sciences Center, State University of Maringá-UEM, Colombo Avenue, 5790, Maringá, Paraná, 87020-900, Brazil.
BMC Womens Health ; 24(1): 485, 2024 Sep 03.
Article em En | MEDLINE | ID: mdl-39227848
ABSTRACT

BACKGROUND:

The coronavirus 2019 (COVID-19) pandemic impacted cancer health care in several countries, with delays in the detection and treatment of breast and cervical cancer. The objective of this study is to analyze and compare the screening, diagnosis and treatment of breast and cervical cancer in the pre-COVID period and during the COVID-19 period.

METHODS:

Cross-sectional study with secondary data collected from the Mortality Information System (SIM), Hospital Information System (SIH), Ambulatory Information System (SIA) and the Oncology Panel (PO) of breast cancer notifications with ICD C50.0 to C50.9 and cervix ICD C53.0 to C53.9, The analyzed period before the pandemic was from March 1 to October 1, 2019, and during the pandemic from March 1 to October 1, 2020. The period from 2013 to 2022 was also analyzed with the same information, including the number of diagnoses, treatments, and deaths from breast cancer and cervical cancer. The study population consisted of Brazilian women aged 25 to 70 years. In order to compare categorical variables between periods, the Chi-Square or Fisher's Exact tests, and Mann-Whitney U tests were applied, and the Poisson Regression model was applied to model the number of reported cases of COVID-19 and the amount of procedures.

RESULTS:

There was a decrease in the number of mammograms and cytopathological exams during COVID-19, as well as a decrease in cases of breast and cervical cancer. The Poisson regression showed that the increase in the number of COVID-19 cases caused a decrease in the number of breast cytopathological examinations, cervical-vaginal cytopathological examinations/microflora and screening, diagnosis, initiation of treatment for breast cancer and deaths from this disease. Meanwhile, in some regions of Brazil, as the number of Covid-19 increased, there was a significantly increase in the number of mammograms performed and cervical cancer diagnoses.

CONCLUSIONS:

The COVID-19 period in 2020 significantly impacted screening, diagnosis, treatment for breast and cervical cancer.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias do Colo do Útero / Detecção Precoce de Câncer / COVID-19 Limite: Adult / Aged / Female / Humans / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: BMC Womens Health Assunto da revista: SAUDE DA MULHER Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias do Colo do Útero / Detecção Precoce de Câncer / COVID-19 Limite: Adult / Aged / Female / Humans / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: BMC Womens Health Assunto da revista: SAUDE DA MULHER Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido